USPTO trademark

Everest Clinical Research Corporation design mark 50146585

Under examinationUSPTOFigurative markClass 9Class 42

"Design mark 50146585" is a figurative mark owned by Everest Clinical Research Corporation, filed at the USPTO on October 6, 2026. It is under examination and covers classes 9 and 42.

Official USPTO record
Everest Clinical Research Corporation design mark 50146585 trademark as filed
As filed with the USPTO
Status
Under examination
Since October 6, 2026
Filed
October 6, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50146585
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Figurative mark
2 classes
Ownership

Who owns Everest Clinical Research Corporation design mark 50146585

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services Everest Clinical Research Corporation design mark 50146585 is filed for, grouped by Nice class.

  • Downloadable computer software for capturing, reporting, and processing of data in pharmaceutical industry clinical trials; recorded computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient-reported outcomes in pharmaceutical industry clinical trials; recorded computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient-reported outcomes in pharmaceutical industry clinical trials on handhelds and PDAs; downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient-reported outcomes in pharmaceutical industry clinical trials; downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient-reported outcomes in pharmaceutical industry clinical trials on handhelds and PDAs; downloadable mobile applications for generating patient-reported outcome reports in pharmaceutical industry clinical trials; downloadable software for enabling patients to select a medication from a list of their frequent medications, select a new drug or therapy, and enter all medication intake, and for adding the aforementioned information to existing study questionnaires as a way to record concomitant medications; Downloadable computer software and downloadable mobile application software for use in clinical trials and clinical research for the collection, capture, processing, transmission, storage, synchronization, reporting, and management of electronic clinical outcome assessment (eCOA) data, patient-reported outcomes (ePRO), electronic diaries (eDiary), electronic clinician-reported outcomes (eClinRO), electronic observer-reported outcomes (ObsRO), and performance outcome assessments (PerfO); downloadable computer software and downloadable mobile application software featuring reminders, alerts, notifications, training materials, administration of assessments and questionnaires, compliance monitoring, real-time reporting, offline data capture, and data synchronization for use in pharmaceutical, biotechnology, medical device, and clinical research studies

  • Software as a service (SaaS) services featuring software for use in clinical trials and clinical research for the collection, capture, processing, transmission, storage, synchronization, reporting, and management of electronic clinical outcome assessment (eCOA) data, patient-reported outcomes (ePRO), electronic diaries (eDiary), electronic clinician-reported outcomes (eClinRO), electronic observer-reported outcomes (ObsRO), and performance outcome assessments (PerfO); non-downloadable computer software for use in clinical trials and clinical research for the collection, capture, processing, transmission, storage, synchronization, reporting, and management of electronic clinical outcome assessment (eCOA) data, patient-reported outcomes (ePRO), electronic diaries (eDiary), electronic clinician-reported outcomes (eClinRO), electronic observer-reported outcomes (ObsRO), and performance outcome assessments (PerfO); providing temporary use of non-downloadable software featuring reminders, alerts, notifications, training materials, administration of assessments and questionnaires, compliance monitoring, real-time reporting, offline data capture, and data synchronization for use in pharmaceutical, biotechnology, medical device, and clinical research studies

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application entered
FAQ

About Everest Clinical Research Corporation design mark 50146585

Who owns the trademark "Design mark 50146585"?

The USPTO trademark "Design mark 50146585" (application 50146585) is owned by Everest Clinical Research Corporation.

What is the status of "Design mark 50146585"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Everest Clinical Research Corporation design mark 50146585 and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_01a11679-b6b0-75de-b3b2-8ba053c3bf75
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a11679-b6b0-75de-b3b2-8ba053c3bf75",
  "object": "trademark",
  "mark_text": "[Design Mark]",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50146585",
  "filing_date": "2026-10-06",
  "nice_classes": [
    9,
    42
  ],
  "owners": [
    {
      "name": "Everest Clinical Research Corporation",
      "entity_id": "ent_019eb715-ddf9-759b-9aa9-368cd85befbc"
    }
  ]
}